Procalcitonin-Guided Care Cut Antibiotic Use in Acute Pancreatitis
(MedPage Today) -- Using procalcitonin-based algorithms reduced the use of antibiotics in patients with acute pancreatitis, with no increased risk of infection or harm, a randomized trial in the U.K. showed. In an intention-to-treat analysis involving... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 22, 2022 Category: Gastroenterology Source Type: news

Is Pre-endoscopy COVID Testing Still Needed? Is Pre-endoscopy COVID Testing Still Needed?
Personal protective equipment and COVID-19 vaccination might be enough to reduce COVID-19 transmission.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 22, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Endoscopic Balloon Dilation Effective for Small Bowel Strictures Endoscopic Balloon Dilation Effective for Small Bowel Strictures
New study shows favorable 5-year outcomes for treatment of small bowel strictures with endoscopic balloon dilation in patients with Crohn ' s disease.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 22, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Biologic Choice May Affect Perianal Crohn's Disease Outcomes Biologic Choice May Affect Perianal Crohn's Disease Outcomes
This phenotype is aggressive, but there ' s only limited data on whether using a biologic at diagnosis can alter long-term outcomes.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 22, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Biden to tap prominent Harvard cancer surgeon to head National Cancer Institute
President Joe Biden is expected to pick cancer surgeon Monica Bertagnolli as the next director of the National Cancer Institute (NCI). Bertagnolli, a physician-scientist at the Dana-Farber Cancer Institute in Boston and Harvard Medical School, specializes in gastrointestinal cancers and is well known for her expertise in clinical trials. She will replace Ned Sharpless, who stepped down as NCI director in April after nearly 5 years. The White House has not yet announced the selection, first reported by STAT , but several cancer research organizations closely watching for the nomination hav...
Source: ScienceNOW - July 21, 2022 Category: Science Source Type: news

Serrated Polyp Detection a Good Indicator of Colonoscopy Quality
(MedPage Today) -- While the adenoma detection rate (ADR) is a well-established quality indicator for colonoscopy, the proximal serrated polyp detection rate (PSPDR) should be used as a complementary tool, according to a Dutch population-based... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news

Job Market for Docs, Advanced Practitioners Rebounds: Report Job Market for Docs, Advanced Practitioners Rebounds: Report
A review of search assignments by healthcare organizations shows the job market for new physicians and advanced practitioners is roaring back — but still feeling lingering pandemic affects.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 21, 2022 Category: Gastroenterology Tags: Family Medicine/Primary Care News Source Type: news

Falsified IBS Data; Patients' Top Choice for CRC Screening; Fertility and IBD Drugs
(MedPage Today) -- Two women from Florida pleaded guilty in connection to a conspiracy to falsify data for clinical trials evaluating therapies for irritable bowel syndrome (IBS), among other conditions, the Department of Justice announced. Doctors... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news

Episode 4: Anti-IL-23 Medications and Durable Remission in Crohn's Disease Episode 4: Anti-IL-23 Medications and Durable Remission in Crohn's Disease
Drs Peter Higgins and Raja Atreya discuss the phenomenon of durable drug-free remission in certain patients with Crohn ' s disease and the future of intermittent induction and sequencing of therapies.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2022 Category: Consumer Health News Tags: Gastroenterology InDiscussion Source Type: news

Diabetes Drug for Bile Acid Diarrhea Bests Standard of Care in Small Trial
(MedPage Today) -- Glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide (Victoza, Saxenda) may be superior to colesevelam (Welchol) for reducing stool frequency in patients with moderate-to-severe bile acid diarrhea, a small randomized... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news

Management of Refractory Eosinophilic Esophagitis Management of Refractory Eosinophilic Esophagitis
Refractory eosinophilic esophagitis remains challenging to treat. Review reasons for non-response to therapy and options for these patients in this paper.Current Opinion in Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follicular lymphoma) andT...
Source: Roche Investor Update - July 21, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Basel, 21 July 2022Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follic...
Source: Roche Media News - July 21, 2022 Category: Pharmaceuticals Source Type: news

Smartphone Tool Helps Gauge Bowel Prep Quality Before Colonoscopy Smartphone Tool Helps Gauge Bowel Prep Quality Before Colonoscopy
An AI tool that runs on a smartphone may be an alternative approach for evaluating the quality of bowel preparation before colonoscopy, particularly in the era of COVID-19.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 21, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Relapse Patterns in Chronic Hep B After Halting Treatment
(MedPage Today) -- Chronic hepatitis B patients who discontinued tenofovir disoproxil fumarate (TDF, Viread) after achieving viral suppression had higher rates of clinical relapse compared to those who stopped entecavir, a global retrospective... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news